Abstract
Meeting abstracts Many therapies such as surgery, chemical or physical approaches have been used for treatment of HCC; however, the outcome is still poor. Cancer immunotherapy is considered to be one of the promising strategies in recent years. Expression of CTAs genes including MAGE A3, MAGE A4,
Highlights
Many therapies such as surgery, chemical or physical approaches have been used for treatment of HCC; the outcome is still poor
Expression of CTAs genes including MAGE A3, MAGE A4, MAGE C2 and NY-ESO-1 genes was detected with reverse transcription polymerase chain reaction (RTPCR) in HCC tissues and corresponding adjacent noncancerous tissues from 71 HCC patients
87.3% of HCC tumor tissue samples expressed at least 1 CTAs
Summary
Meng Wang1,2*, Xin-feng Chen, Zhi-qin Li3, Zhen Zhang, Dong-li Yue, Yan-hong Liu, Dong Jiang, Yu-ling Sun, Yong-fu Zhao, Shu-huan Wu3, Jian-sheng Li1, Yi Zhang. From Society for Immunotherapy of Cancer 28th Annual Meeting National Harbor, MD, USA. From Society for Immunotherapy of Cancer 28th Annual Meeting National Harbor, MD, USA. 8-10 November 2013
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
